Last reviewed · How we verify
NCT05901740
Prevalence of Fuctional Heartburn in Patients With IBS .
trial in Heartburn in 100 participants. Status unknown.
1 July 2024
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 July 2023 |
| Primary completion | 1 July 2024 |
| Estimated completion | 1 August 2024 |
Conditions studied
- Heartburn — all drugs for Heartburn →
Sponsor
Assiut University
Who can join
18 and older, any sex, with Heartburn. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess prevalence of functional heartburn in IBS patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05901740
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heartburn
Currently open trials in the same condition.
- NCT07379645 — A Clinical Trial of PepZinGI® for Acute Heartburn Relief and Sleep Outcomes · NA · recruiting
- NCT06098742 — Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg · NA · recruiting
- NCT05976165 — A Study of Breath Testing for Small Intestinal Bacterial Overgrowth · NA · recruiting
- NCT05629143 — Primary carE PPi dEprescRibing Trial · Phase 4 · active not recruiting
- NCT01696734 — Domperidone in Treating Patients With Gastrointestinal Disorders · Phase 3 · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05901740 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 13 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05901740.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing